Elsevier

Neuroscience

Volume 57, Issue 3, December 1993, Pages 673-681
Neuroscience

Chronic continuous and intermittentl-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats—an autoradiographic study using [3H]flunitrazepam

https://doi.org/10.1016/0306-4522(93)90014-7Get rights and content

Abstract

The effects of chronic ‘continuous’ and ‘intermittent’l-3,4-dihydroxyphenylalanine treatments on GABA receptor function in the basal ganglia of rats with unilateral 6-hydroxydopamine lesions of the medial forebrain bundle was investigated, by autoradiography with [3H]flunitrazepam. The 6-hydroxy-dopamine lesion itself, increased [3H]flunitrazepam binding in the substantia nigra pars reticulata (+ 17%, with respect to intact side) and entopeduncular nucleus (+44%), but decreased binding in the globus pallidus of the denervated hemisphere (−20%). ‘Intermittent’l-3,4-dihydroxyphenylalanine treatment reduced the [3H]flunitrazepam binding changes observed in the substantia nigra pars reticulata (−13%) and entopeduncular nucleus (−4%), whereas ‘continuous’ infusion of the same daily dose ofl-3,4-dihy-droxyphenylalanine had less effect (+14%, substantia nigra pars reticulata; +26%, entopeduncular nucleus). In contrast, the [3H]flunitrazepam binding decrease in the globus pallidus of the 6-hydroxydopamine lesioned animals was unaffected by either regime of chronicl-3,4-dihydroxyphenylalanine treatment. The changes in GABA receptor function implied by these results provide further insight into the pathophysiological effects ofl-3,4-dihydroxyphenylalanine treatment on basal ganglia function, following dopamine denervation.

In accordance with existing electrophysiological and biochemical evidence on this subject, the main implications of these results include reduced GABA sensitivity of neurons in the entopeduncular nucleus and substantia nigra pars reticulata, following chronic ‘intermittent’, but not chronic ‘continuous’l-3,4-dihydroxyphenylalanine treatment; this may be due to a reversal of the 6-hydroxydopamine induced decrease in the GABA-mediated neurotransmission in the striatoentopeduncular and striatonigral pathways. In contrast, the regulation of GABA receptors in the globus pallidus does not appear to be subject to modulation by chronicl-3,4-dihydroxyphenylalanine administration, suggesting that dopamine replacement in this manner does not modify the 6-hydroxydopamine induced increase in GABA-mediated neurotransmission in the stratopallidal pathway.

Reference (46)

  • HarrisonM.B. et al.

    Selective localization of striatal D-1 receptors to striatonigral neurons

    Brain Res.

    (1990)
  • La HosteG.J. et al.

    Nigral D-1 and striatal D-2 receptors mediate the behavioural effects of dopamine agonists

    Behav. Brain Res.

    (1990)
  • LindvallO. et al.

    Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway

    Brain Res.

    (1979)
  • LoopuijtL.D. et al.

    Organisation of the striatum: collateralisation of its efferent axons

    Brain Res.

    (1985)
  • MitchellI.J. et al.

    Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Neuroscience

    (1989)
  • ParentA. et al.

    Distinct afferents to internal and external pallidal segments in the squirrel monkey

    Neurosci. Lett.

    (1989)
  • RobertsonG.S. et al.

    Evidence that the substantia nigra is a site of action forl-Dopa

    Neuroscience

    (1988)
  • RobertsonG.S. et al.

    Striatonigral projection neurones contain D-1 dopamine receptor activated c-fos

    Brain Res.

    (1990)
  • RobertsonG.S. et al.

    D-1 and D-2 dopamine receptors differentially regulatec-fos expression in striatonigral and striatopallidal neurons

    Neuroscience

    (1992)
  • RobertsonR.G. et al.

    Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of γ-aminobutyric acid in the lateral segment of the globus pallidus

    Brain Res.

    (1991)
  • SegoviaJ. et al.

    Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation

    Neuropharmacology

    (1987)
  • SegoviaJ. et al.

    Gamma-aminobutyric acid release in the globus pallidusin vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat

    Neurosci. Lett.

    (1986)
  • TrugmanJ.M. et al.

    The effects ofl-Dopa on regional cerebral glucose utilisation in rats with unilateral lesions of the substantia nigra

    Brain Res.

    (1986)
  • Cited by (39)

    • Pathophysiology of Parkinsonism

      2008, Clinical Neurophysiology
      Citation Excerpt :

      Such changes are thought to be compensatory, and therefore opposite in polarity to the changes in GABAergic activity. Consistent with increased GABA release in GPe and reduced GABAergic inhibition of GPi and SNr, there are decreases in GABA-A and GABA-B receptor binding or mRNA expression for these receptors in GPe, and increases in GPi/SNr, in parkinsonian patients or animals (e.g., Calon et al., 1999; Chadha et al., 2000; Gnanalingham and Robertson, 1993; Griffiths et al., 1990; Katz et al., 2005; Pan et al., 1985; Robertson et al., 1990). Besides the GABAergic system, glutamatergic transmission has also been evaluated.

    • Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA<inf>A</inf> receptor α1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion

      2008, Neuroscience
      Citation Excerpt :

      Another new finding in this study is that acute or subchronic SKF-81297 induced a down-regulation of post-synaptic GABAA receptors in the SNr on the side ipsilateral to the 6-OHDA lesion. Previous studies have shown that similar effects can be elicited by the chronic or subchronic systemic administration of l-DOPA (Gnanalingham and Robertson, 1993; Katz et al., 2005). In our study, we show that the effects can be detected as early as 3 h after a single administration of SKF-81297 although they reached statistical significance only at 72 h.

    • Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic l-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata

      2007, Neuroscience
      Citation Excerpt :

      In any case, the finding that the 6-OHDA lesion had a dual effect on vGAT expression in presumed striatopallidal and striatonigral neurons supports the idea that GABA neurotransmission is oppositely affected in the two major subsets of striatal efferent neurons. This idea is otherwise supported by ligand binding and in situ hybridization studies showing that the expression of GABAA receptors or their subunits is decreased in the globus pallidus and increased in the SNr or entopeduncular nucleus on the side ipsilateral to a unilateral 6-OHDA lesion in the adult rat (Pan et al., 1985; Gnanalingham and Robertson, 1993; Chadha et al., 2000; Nielsen and Soghomonian, 2004; Katz et al., 2005). Our results thus suggest that the altered expression of GABAA receptors in the globus pallidus or SNr induced by a 6-OHDA lesion of DA neurons represents a compensatory response to altered vesicular GABA release from striatal afferent inputs.

    • GABAergic circuits in the basal ganglia and movement disorders

      2007, Progress in Brain Research
      Citation Excerpt :

      There are many reports of changes in expression levels of both types of GABA receptors in parkinsonism. For example, GABA-A receptor binding has been found to be decreased in GPe and increased in GPi and SNr of parkinsonian patients (Griffiths et al., 1990) or animals (e.g., Pan et al., 1985; Robertson et al., 1990; Gnanalingham and Robertson, 1993; Calon et al., 1999; Chadha et al., 2000b). These changes are likely to be compensatory in nature, counteracting changes in GABA levels (see above).

    • Globus pallidus internal segment

      2007, Progress in Brain Research
      Citation Excerpt :

      The mechanism of changes in their discharge patterns remains to be studied. However, an upregulation and a downregulation of GABAA receptors in the GPi and GPe, respectively, were reported in parkinsonian rats (Gnanalingham and Robertson, 1993), monkeys (Robertson et al., 1990; Calon et al., 1995, 1999), and patients (Griffiths et al., 1990; Calon et al., 2003). These changes in GABAA receptors can be attributed mainly to the changes in α1 and β2 GABAA receptor subunit gene expression (Chadha et al., 2000).

    View all citing articles on Scopus
    View full text